Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Complementary biobank of rodent tissue samples to study the effect of World Trade Center exposure on cancer development.

Lieberman-Cribbin W, Tuminello S, Gillezeau C, van Gerwen M, Brody R, Mulholland DJ, Horton L, Sisco M, Prophete C, Zelikoff J, Lee HW, Park SH, Chen LC, Cohen MD, Taioli E.

J Transl Med. 2019 Oct 11;17(1):342. doi: 10.1186/s12967-019-2089-7.

2.

Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer.

Bryant G, Wang L, Mulholland DJ.

Int J Mol Sci. 2017 Jul 17;18(7). pii: E1542. doi: 10.3390/ijms18071542. Review.

3.

Strategies to avoid treatment-induced lineage crisis in advanced prostate cancer.

Roubaud G, Liaw BC, Oh WK, Mulholland DJ.

Nat Rev Clin Oncol. 2017 May;14(5):269-283. doi: 10.1038/nrclinonc.2016.181. Epub 2016 Nov 22. Review.

4.

Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model.

Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ.

PLoS One. 2016 Mar 21;11(3):e0152243. doi: 10.1371/journal.pone.0152243. eCollection 2016. No abstract available.

5.

HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.

Ruscetti M, Dadashian EL, Guo W, Quach B, Mulholland DJ, Park JW, Tran LM, Kobayashi N, Bianchi-Frias D, Xing Y, Nelson PS, Wu H.

Oncogene. 2016 Jul 21;35(29):3781-95. doi: 10.1038/onc.2015.444. Epub 2015 Dec 7.

6.

Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.

Hu X, Garcia C, Fazli L, Gleave M, Vitek MP, Jansen M, Christensen D, Mulholland DJ.

Sci Rep. 2015 Nov 13;5:15182. doi: 10.1038/srep15182.

7.

Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model.

Liang M, Adisetiyo H, Li X, Liu R, Gill P, Roy-Burman P, Jones JO, Mulholland DJ.

PLoS One. 2015 Jul 21;10(7):e0131232. doi: 10.1371/journal.pone.0131232. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0152243. Liu, Xiuqing [corrected to Li, Xiuqing].

8.

Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis.

Ruscetti M, Quach B, Dadashian EL, Mulholland DJ, Wu H.

Cancer Res. 2015 Jul 1;75(13):2749-59. doi: 10.1158/0008-5472.CAN-14-3476. Epub 2015 May 6.

9.

Lipogenic metabolism: a viable target for prostate cancer treatment?

Liang M, Mulholland DJ.

Asian J Androl. 2014 Sep-Oct;16(5):661-3. doi: 10.4103/1008-682X.132947.

10.

PSA-negative/low prostate cancer cells: the true villains of CRPC?

Mulholland DJ.

Asian J Androl. 2012 Sep;14(5):663-4. doi: 10.1038/aja.2012.69. Epub 2012 Jul 23. No abstract available.

11.

JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate.

Hübner A, Mulholland DJ, Standen CL, Karasarides M, Cavanagh-Kyros J, Barrett T, Chi H, Greiner DL, Tournier C, Sawyers CL, Flavell RA, Wu H, Davis RJ.

Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12046-51. doi: 10.1073/pnas.1209660109. Epub 2012 Jul 2.

12.

Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.

Mulholland DJ, Kobayashi N, Ruscetti M, Zhi A, Tran LM, Huang J, Gleave M, Wu H.

Cancer Res. 2012 Apr 1;72(7):1878-89. doi: 10.1158/0008-5472.CAN-11-3132. Epub 2012 Feb 20.

13.

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.

Mulholland DJ, Tran LM, Li Y, Cai H, Morim A, Wang S, Plaisier S, Garraway IP, Huang J, Graeber TG, Wu H.

Cancer Cell. 2011 Jun 14;19(6):792-804. doi: 10.1016/j.ccr.2011.05.006. Epub 2011 May 27.

14.

Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.

Mulholland DJ, Xin L, Morim A, Lawson D, Witte O, Wu H.

Cancer Res. 2009 Nov 15;69(22):8555-62. doi: 10.1158/0008-5472.CAN-08-4673. Epub 2009 Nov 3.

15.

Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex.

Mosessian S, Avliyakulov NK, Mulholland DJ, Boontheung P, Loo JA, Wu H.

J Biol Chem. 2009 Oct 30;284(44):30159-66. doi: 10.1074/jbc.M109.027995. Epub 2009 Sep 9.

16.

Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.

Burton JB, Johnson M, Sato M, Koh SB, Mulholland DJ, Stout D, Chatziioannou AF, Phelps ME, Wu H, Wu L.

Nat Med. 2008 Aug;14(8):882-8. doi: 10.1038/nm.1727. Epub 2008 Jul 11.

17.

Hormone refractory prostate cancer: Lessons learned from the PTEN prostate cancer model.

Mulholland DJ, Jiao J, Wu H.

Adv Exp Med Biol. 2008;617:87-95. doi: 10.1007/978-0-387-69080-3_8. Review. No abstract available.

PMID:
18497033
18.

PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression.

Chang CJ, Mulholland DJ, Valamehr B, Mosessian S, Sellers WR, Wu H.

Mol Cell Biol. 2008 May;28(10):3281-9. doi: 10.1128/MCB.00310-08. Epub 2008 Mar 10.

19.

Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor.

Memarzadeh S, Xin L, Mulholland DJ, Mansukhani A, Wu H, Teitell MA, Witte ON.

Cancer Cell. 2007 Dec;12(6):572-85.

20.

Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.

Kojima S, Mulholland DJ, Ettinger S, Fazli L, Nelson CC, Gleave ME.

Prostate. 2006 Jun 15;66(9):971-86.

PMID:
16541420
21.

PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.

Mulholland DJ, Dedhar S, Wu H, Nelson CC.

Oncogene. 2006 Jan 19;25(3):329-37. Review.

PMID:
16421604
22.

Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?

Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC.

Endocr Rev. 2005 Dec;26(7):898-915. Epub 2005 Aug 26. Review.

PMID:
16126938
23.

Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft.

Rocchi P, Muracciole X, Fina F, Mulholland DJ, Karsenty G, Palmari J, Ouafik L, Bladou F, Martin PM.

Oncogene. 2004 Dec 2;23(56):9111-9.

PMID:
15489889
24.

Androgen responsiveness of Renilla luciferase reporter vectors is promoter, transgene, and cell line dependent.

Mulholland DJ, Cox M, Read J, Rennie P, Nelson C.

Prostate. 2004 May 1;59(2):115-9.

PMID:
15042611
25.
26.

Testis fascin (FSCN3): a novel paralog of the actin-bundling protein fascin expressed specifically in the elongate spermatid head.

Tubb B, Mulholland DJ, Vogl W, Lan ZJ, Niederberger C, Cooney A, Bryan J.

Exp Cell Res. 2002 Apr 15;275(1):92-109.

PMID:
11925108
27.

The androgen receptor can promote beta-catenin nuclear translocation independently of adenomatous polyposis coli.

Mulholland DJ, Cheng H, Reid K, Rennie PS, Nelson CC.

J Biol Chem. 2002 May 17;277(20):17933-43. Epub 2002 Feb 20.

28.
30.

Distribution of actin bundles in Bowman's capsule of rat kidney.

Mulholland DJ, Wilson J, Vogl W, Webber W.

Tissue Cell. 1999 Dec;31(6):610-6.

PMID:
10669934
31.

A national survey of graduate students in Canadian Departments of Anatomy and Cell Biology.

Mulholland DJ, Webber WA, Slonecker CE.

Anat Rec. 1999 Oct 15;257(5):157-61. No abstract available.

32.
33.

Rat testis motor proteins associated with spermatid translocation (dynein) and spermatid flagella (kinesin-II).

Miller MG, Mulholland DJ, Vogl AW.

Biol Reprod. 1999 Apr;60(4):1047-56.

PMID:
10084983
34.

Academic performance in children of divorce: psychological resilience and vulnerability.

Mulholland DJ, Watt NF, Philpott A, Sarlin N.

Psychiatry. 1991 Aug;54(3):268-80.

PMID:
1946827
35.

Extralobar lung sequestration associated with fatal neonatal respiratory distress.

Bliek AJ, Mulholland DJ.

Thorax. 1971 Jan;26(1):125-30. No abstract available.

Supplemental Content

Loading ...
Support Center